Page results
-
This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment. It explains what the treatment involves, how to prepare for it and what you can expect afterwards.
-
We are now administering new COVID-19 treatments for patients at highest risk in the community. The service can prescribe oral antivirals to be taken at home, and give intravenous antibody treatments at the hospital.
-
Dr Zandi is a consultant neurologist. He works on central and peripheral nervous system neuroimmunological diseases, particularly autoimmune encephalitis (eg. associated with NMDAR, LGI1 or related autoantibodies, COVID-19 neurology), with a broader research interest in all central and peripheral neuroimmunology, CNS vasculitis and amyloid related angiopathy, neurological involvement in systemic lupus erythematosus and related rheumatological conditions.
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
UCLH has continued to achieve excellent results in the National Inpatient Survey, with patients rating their overall care as 8.7 out of 10 – the top score amongst our London peers.
-
Functional dyspepsia and gastroparesis often co-exist. There are good treatment pathways for managing the symptoms associated with these conditions.
-
UCH Chemotherapy Daycare and the Macmillan Support and Information Service are shortlisted for a Patient Experience Network National Award for the use of data from the Cancer Patient Experience Survey to improve patient experience.
-
Zero carbon, virtual appointments, specialist advice in primary care settings, thousands using online services, remote monitoring and digitising admin tasks: these are just some of the ways we will achieve patient-centred, integrated, excellent care for our patients as set out in our new outpatient strategy.
-
Court of Appeal has ruled in favour of the Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS).
-
I would like to make a payment to UCLH, I have a query about reclaiming expenses for treatment or transport at University College Hospital or I have a query about expenses for treatment or transport at Queen Square (NHNN/RLHIM)
File results
-
FOI/2023/0462 - Patients to hotels
-
FOI/2019/514 Benchmarking tool
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0292 - Spend on bank/ agency/ locum staff for junior doctor strike cover
-
FOI/2019/468 Rheumatoid Arthritis biologic pathway
-
FOI/2019/484 Homless patients admitted to ED
-
FOI/2019/516 TMS and SCS protocols, guidelines and treatment pathways
-
FOI/2019/597 In-house stop smoking service for patients
-
FOI/2019/524 UCLH Phase 5 contractors
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022